Temporally Splitting Ovarian Stimulation and Embryo Transfer

This study has been completed.
Sponsor:
Information provided by:
University of Luebeck
ClinicalTrials.gov Identifier:
NCT00795041
First received: November 20, 2008
Last updated: October 15, 2010
Last verified: November 2008
  Purpose

The purpose of this study is to explore the concept of temporally splitting ovarian stimulation and embryo transfer.


Condition
Splitting of Ovarianstimulation and Embryotransfer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Temporally Splitting Ovarian Stimulation and Embryo Transfer

Further study details as provided by University of Luebeck:

Primary Outcome Measures:
  • Ongoing pregnancy rate [ Time Frame: November 2008- May 2009 ] [ Designated as safety issue: No ]

Enrollment: 10
Study Start Date: November 2008
Study Completion Date: September 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
10 women with indication for ART with ICSI or IVF

  Eligibility

Ages Eligible for Study:   18 Years to 36 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

women with indication for ART with ICSI or IVF

Criteria

Inclusion Criteria:

  • Indication for IVF/ICSI
  • Age 18-36 years
  • <= three earlier unsuccessful IVF/ICSI treatments with embryo transfer
  • BMI 20-30
  • Regular cycle with ovulation (28-35 days)
  • Progesterone >7ng/ml at the beginning of stimulation
  • Informed consents

Exclusion Criteria:

  • PCOS (polycystic ovarian syndrome
  • Endometrioses >= grade 3
  • Known poor response syndrome
  • History of ovariectomy
  • Severe endocrinopathie
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00795041

Locations
Germany
University Hospital of Schleswig Holstein, Campus Luebeck, Department of Obstetrics and Gynecology
Luebeck, Schleswig-Holstein, Germany, 23538
Sponsors and Collaborators
University of Luebeck
Investigators
Principal Investigator: Georg Griesinger, PD MD University of Schleswig-Holstein, Campus Luebeck, Department of Obstetrics and Gynecology
  More Information

No publications provided

Responsible Party: Buendgen N.; Griesinger G. PD Dr. med., University Hospital of SH, Campus Luebeck, Deparment of Obstetrics/Gynecology
ClinicalTrials.gov Identifier: NCT00795041     History of Changes
Other Study ID Numbers: TS1
Study First Received: November 20, 2008
Last Updated: October 15, 2010
Health Authority: Germany: Ministry of Health

Keywords provided by University of Luebeck:
vitrification
ovarian stimulation
reproductive medicine

ClinicalTrials.gov processed this record on April 17, 2014